For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220706:nRSF5757Ra&default-theme=true
RNS Number : 5757R Spire Healthcare Group PLC 06 July 2022
6 July 2022
Spire Healthcare Group plc
Notification of Transactions by Directors and Persons Discharging Managerial
Responsibilities ("PDMRs")
Exercise of Sharesave (SAYE) Plan options
Spire Healthcare Group plc (the "Company") announces the following changes to
the interests of the Directors and PDMRS listed below in the Company's
ordinary shares of 1 pence each ('Shares'). This announcement is made in
accordance with Article 19 of the Market Abuse Regulation and Rule 3.1 of the
Disclosure and Transparency Rules.
On 1 June 2022, the options granted on 2 May 2019 under the Company's
Sharesave Plan reached maturity and became capable of exercise.
The PDMRs noted below exercised their options and acquired Shares at the
exercise price of £1.09 on 5 July 2022. All Shares acquired have been
retained by the individuals concerned. The exercise price was set at the point
of grant and was determined in accordance with the valuation methodology
agreed with HM Revenue & Customs and the rules of the Sharesave Plan.
Directors Number of Ordinary Shares acquired Exercise Price per Ordinary Share
Justin Ash 3,302 £1.09
Jitesh Sodha 3,302 £1.09
Other PDMRs Number of Ordinary Shares acquired Exercise Price per Ordinary Share
John Forrest 3,302 £1.09
Harbant Samra 3,302 £1.09
Name of contact and telephone number for queries:
Philip Davies
07803
508348
Company Secretary
The information set out below is provided in accordance with the requirements
of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Justin Ash
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of options under the Spire Healthcare Group plc Sharesave plan. All
shares have been retained.
c) Price(s) and volume(s) Price(s) Volume(s)
£1.09 3,302
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-07-05
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Jitesh Sodha
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of options under the Spire Healthcare Group plc Sharesave plan. All
shares have been retained.
c) Price(s) and volume(s) Price(s) Volume(s)
£1.09 3,302
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-07-05
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name John Forrest
2 Reason for the notification
a) Position/status Chief Operating Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of options under the Spire Healthcare Group plc Sharesave plan. All
shares have been retained.
c) Price(s) and volume(s) Price(s) Volume(s)
£1.09 3,302
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-04-26
f) Place of the transaction XLON
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Harbant Samra
2 Reason for the notification
a) Position/status Interim Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of options under the Spire Healthcare Group plc Sharesave plan. All
shares have been retained.
c) Price(s) and volume(s) Price(s) Volume(s)
£1.09 3,302
d) Aggregated information As above
- Aggregated volume
- Price
e) Date of the transaction 2022-07-05
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDRRUGDGDL